Phosphodiesterase-3 inhibitor
Kawagoe, Y.; Hattori, Y.; Kasai, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 186-189
2010
ISSN/ISBN: 0047-1852 PMID: 21661155 Document Number: 640475
Document emailed within 1 workday
Related Documents
Nicholson, C.D.; Shahid, M.; Bruin, J.; Barron, E.; Spiers, I.; de Boer, J.; van Amsterdam, R.G.; Zaagsma, J.; Kelly, J.J.; Dent, G. 1995: Characterization of ORG 20241, a combined phosphodiesterase IV/IIi cyclic nucleotide phosphodiesterase inhibitor for asthma Journal of Pharmacology and Experimental Therapeutics 274(2): 678-687Sills, T.; Heptinstall, S. 1986: Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour Thrombosis and Haemostasis 55(3): 305-308
Kakinuma, Y.; Miyauchi, T. 2001: Endothelin receptor antagonist, phosphodiesterase inhibitor, thromboxane inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 59(6): 1139-1144
Chen, C.-Y. 2005: Practical enantioselective process for a chiral phosphodiesterase-4 inhibitor Current Opinion in Drug Discovery and Development 8(6): 709-722
Chiu, N.; Park, I.; Reid, I.A. 1996: Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram Journal of Pharmacology and Experimental Therapeutics 276(3): 1073-1077
Jackson, C.; Ball, J.; Peel, J.; Lawry, J.; Greaves, M.; Preston, F.E. 1989: DN 9693: a phosphodiesterase inhibitor with a platelet membrane effect Thrombosis and Haemostasis 61(2): 266-269
Braner, D.A.; Fineman, J.R.; Chang, R.; Soifer, S.J. 1993: M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs American Journal of Physiology 264(1 Pt 2): H252-H258
Samra, S.S.; Bajaj, P.; Vijayaraghavan, K.S.; Potdar, N.P.; Vyas, D.; Devani, R.G.; Ballary, C.; Desai, A. 2003: Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication Journal of the Indian Medical Association 101(9): 561-564
Sankaran, K. 1986: Endogenous protein inhibitor of mitochondrial c-AMP phosphodiesterase in tumour bearing rats Indian Journal of Biochemistry and Biophysics 23(2): 66-69
Furuta, Y.; Takahira, T.; Ueno, M. 1985: Effects of 7-ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626), a new phosphodiesterase inhibitor, on the cardiovascular system of the dog Arzneimittel-Forschung 35(5): 827-832
Weber, K.T.; Janicki, J.S.; Jain, M.C. 1986: Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure Journal of Heart Transplantation 5(2): 105-112
Smith, P.F.; Thompson, W.J.; de Haën, C.; Halonen, M.; Palmer, J.D.; Johnson, D.G. 1986: Bronchodilator activity of a nonxanthine phosphodiesterase inhibitor; 2,4-diamino-5-cyano-6-bromopyridine (compound I) Journal of Pharmacology and Experimental Therapeutics 237(1): 114-119
Ankur, J.; Mahesh, R.; Bhatt, S. 2013: Anxiolytic-like effect of etazolate, a type 4 phosphodiesterase inhibitor in experimental models of anxiety Indian Journal of Experimental Biology 51(6): 444-449
Lü, H-Jing.; Qiu, Z-Min.; Wei, W-Li.; Yu, L.; Liu, R-Lin.; Zhang, M. 2004: Effects of phosphodiesterase 4 inhibitor on cough response in guinea pigs sensitized and challenged with ovalbumin Chinese Medical Journal 117(11): 1620-1624
Boolell, M.; Allen, M.J.; Ballard, S.A.; Gepi-Attee, S.; Muirhead, G.J.; Naylor, A.M.; Osterloh, I.H.; Gingell, C. 1996: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction International Journal of Impotence Research 8(2): 47-52
Satake, N.; Durham, J.H.; Brodsky, W.A. 1981: Reversal of the luminal acidification current by a phosphodiesterase inhibitor in the turtle bladder: evidence for active electrogenic biocarbonate secretion Progress in Clinical and Biological Research 73: 13-24
Ohnishi, M.; Oka, M.; Muramatsu, M.; Sato, K.; Kira, S.; Fukuchi, Y. 1999: E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs Journal of Cardiovascular Pharmacology 33(4): 619-624
Parnova, R.G.; Lavrova, E.A.; Bakhteeva, V.T.; Fok, E.M. 2004: Atrial natriuretic factor stimulates the frog urinary bladder osmotic permeability in presence of a cyclic nucleotide phosphodiesterase inhibitor Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 90(2): 212-220
Sugita, M.; Miyakawa, M. 2010: Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example Environmental Health and Preventive Medicine 15(4): 244-251
Sugita, M.; Miyakawa, M. 2010: Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example Environmental Health and Preventive Medicine 15(4): 244-251